scholarly journals Editorial: Lactobacillus GG for diarrhoea in children-reports of its demise have been premature!

2019 ◽  
Vol 49 (12) ◽  
pp. 1533-1534 ◽  
Author(s):  
Eamonn M. M. Quigley
Keyword(s):  
Lactobacillus Gg

scholarly journals Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment

2000 ◽  
Vol 118 (4) ◽  
pp. A814 ◽  
Author(s):  
Levinus A. Dieleman ◽  
Marije S. Goerres ◽  
Annemarie Arends ◽  
Dave Sprengers ◽  
Robin L. Vamey ◽  
...  
Keyword(s):  
Antibiotic Treatment ◽  
Hla B27 ◽  
Transgenic Rats ◽  
Lactobacillus Gg

scholarly journals Strategies for Preventing Endoscopic Recurrence of Crohn’s Disease 1 Year after Surgery: A Network Meta-Analysis

2017 ◽  
Vol 2017 ◽  
pp. 1-8 ◽  
Author(s):  
Jin-shan Feng ◽  
Jin-yu Li ◽  
Xiu-yan Chen ◽  
Zheng Yang ◽  
Shang-hai Li
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Meta Analysis ◽  
Credible Interval ◽  
Ileal Resection ◽  
Randomized Controlled ◽  
Endoscopic Recurrence ◽  
Central Database ◽  
Lactobacillus Gg

Objective. To assess the benefits of different treatments that aim to prevent the endoscopic recurrence of Crohn’s disease (CD) after ileal resection. Methods. Randomized controlled trials (RCTs) were searched from MEDLINE, Embase, and the Cochrane Central Database. All the included RCTs with an endoscopic recurrence outcome which was defined as Rutgeerts’ score ≥ i2 have a duration of more than 1 year. The quality of the included RCTs was assessed by the Cochrane Risk of Bias Tool. Pairwise treatment effects were estimated through a Bayesian random effects network meta-analysis by using the OpenBUGS 1.4 software and reported as odds ratios (ORs) with a 95% credible interval (CI). Results. Fourteen RCTs (877 participants) were included. Two strategies were superior to placebo for preventing endoscopic recurrence of CD at 1 year after surgery: infliximab (d, −5.475; 95% CI, −10.47 to –1.632) and adalimumab (d, −7.273; 95% CI, −13.84 to −2.585). Nine strategies were not effective: budesnoid, mesalazine (in both high and low dose), azathioprine, Tripterygium wilfordii, mesalazine + infliximab, ornidazole, untreated intervention, and Lactobacillus GG. Conclusions. Except for infliximab and adalimumab, other strategies included in our analysis were not effective for preventing endoscopic recurrence of CD at 1 year after ileal resection.

scholarly journals Lactobacillus GG in inducing and maintaining remission of Crohn's disease

2004 ◽  
Vol 4 (1) ◽  
Author(s):  
Michael Schultz ◽  
Antje Timmer ◽  
Hans H Herfarth ◽  
R Balfour Sartor ◽  
Jon A Vanderhoof ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Lactobacillus Gg

Beneficial therapeutic effect Lactobacillus GG in children with abdominal pain: A double-blind placebo-controlled control trial

2008 ◽  
Vol 40 (10) ◽  
pp. A92
Author(s):  
R. Francavilla ◽  
A.M. Magistà ◽  
V.L. Miniello ◽  
E. Lionetti ◽  
A. De Canio ◽  
...  
Keyword(s):  
Abdominal Pain ◽  
Therapeutic Effect ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Lactobacillus Gg

Prevention of antibiotic-associated diarrhea utilizing Lactobacillus GG

1998 ◽  
Vol 114 ◽  
pp. A435 ◽  
Author(s):  
R.J. Young ◽  
D.B. Whitney ◽  
T.L. Hanner ◽  
D.L. Antonson ◽  
J.V. Lupo ◽  
...  
Keyword(s):  
Antibiotic Associated Diarrhea ◽  
Lactobacillus Gg

Lactobacillus GG vaginal suppositories and vaginitis.

1995 ◽  
Vol 33 (5) ◽  
pp. 1433-1433 ◽  
Author(s):  
E Hilton ◽  
P Rindos ◽  
H D Isenberg
Keyword(s):  
Lactobacillus Gg
Sign in / Sign up

Export Citation Format

Share Document